Article Details

FDA Updates for Week of March 4, 2024: Wegovy Gets New Indication

Retrieved on: 2024-03-09 19:22:59

Tags for this article:

Click the tags to see associated articles and topics

FDA Updates for Week of March 4, 2024: Wegovy Gets New Indication. View article details on HISWAI: https://www.managedhealthcareexecutive.com/view/fda-updates-for-week-of-march-4-2024-wegovy-gets-new-indication

Excerpt

Tyenne, Tofidence and Actemra are interleukin-6 (IL-6) receptor antagonists that target specific inflammatory proteins to suppress the immune system.

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up